Julia Robinson is our clinical and science editor.
Health bodies make ‘urgent’ call to Matt Hancock to intervene in the proposed withdrawal of bipolar drugSubscription
The health secretary, Matt Hancock, has been urged to “personally intervene” so that bipolar drug Priadel remains available in the UK with an appropriate pricing structure.
Experts in pain medicine have said they are “deeply concerned” with the “confusing” terminology used in the National Institute for Health and Care Excellence’s draft guidance on chronic pain.
The latest information about the novel coronavirus identified in Wuhan, China, and advice on how pharmacists can help concerned patients and the public.
Recent blog posts
Our research briefings are concise and informative; they keep readers up to date with the latest developments in science and clinical research — from novel uses for existing drugs, to studies assessing potential new treatments.
In 2018, our most popular research briefings covered new areas of research that have been particularly topical this year — including medical cannabis, new antibiotics and e-cigarettes — as well as areas that have long been of interest to pharmacists, such as pain management and adherence.
Julia Robinson summarises the pertinent themes discussed during The Pharmaceutical Journal’s Twitter chat held on Wednesday 12 December 2018.